Announcing our $19,8 million Series A round. Read more here.
AI technology, based on science
.png){kind=logo}
.png)
Idoven has developed the world’s first cardiology-as-a-service platform powered by artificial intelligence that augments a clinician’s ability to identify, triage and diagnose patients at scale.
Our powerful, proprietary AI software leverages electrocardiogram (ECG) data, of any duration and from any device, to improve the accuracy and consistency of ECG interpretation.
We are working with leading pharmaceutical and medical device companies in 3 focus areas:
Our AI software platform for cardiology represents a breakthrough in diagnostic technology to identify arrhythmias and cardiac patterns.
We reduce time and cost of ECG interpretation, while increasing diagnostic capacity. We integrate with any Electronic Health Record (EHR) to triage and diagnose patients at scale.
We develop ECG-related disease biomarkers towards patient identification, risk stratification and prognosis, as well as drug cardiac safety monitoring.
Our algorithms identify high-risk patients that are undiagnosed or under-treated, and predict the effectiveness of treatments.
Our at-home heart monitoring service provides continuous ECG monitoring from 10 seconds to 85 days with a non-invasive device.
Our proprietary algorithms and team of cardiologists analyse the data and deliver a medical-grade report remotely.
ECG hours in database, manually annotated for the sole purpose of AI training
Patients monitored in clinical trials
Collaborators from leading EU and US research centres and industry partners on stroke and atrial fibrillation (MAESTRIA H2020)
Publications in top-tier scientific journals
Prediction models targeting cardiovascular disease under development
Cardiac patterns detected automatically with AI
Our cloud-based infrastructure provides reliability, compliance and security.
Ingests data from standard and proprietary formats.
Analyses ECGs of any duration, to deliver results in minutes.
Works with any ECG device compliant with IEC standards 60601-2-25 / 27 / 47
.png)
We are working with leading pharmaceutical and medical device companies in 3 focus areas:
On May 1, 2019, Iker Casillas, World-cup winning goalkeeper and United Nations Goodwill ambassador, suffered a heart attack during training at the age of 38. Today, he relies on Idoven to care for his heart. Together with the Iker Casillas Foundation, Idoven is able to impact the lives of vulnerable groups at high risk of cardiovascular diseases.
Join Iker, olympic athletes and global tech organisations in the #donateyourheartbeats movement to advance research in the prevention of heart attacks, strokes and other cardiovascular diseases.
Idoven is at the very forefront of advancing AI technology in health and cardiovascular care to help doctors and patients all over the world. We'd like your help.
.png)
_%20Manuel%20Marina%20(Idoven)%20_%20Laura%20Morin%CC%83igo%20(Fitbit).jpg)